36 related articles for article (PubMed ID: 38714850)
1. TRIM58 downregulation maintains stemness via MYH9-GRK3-YAP axis activation in triple-negative breast cancer stem cells.
Li X; Jiang J; Wu Q; You T; Yang F
Cancer Gene Ther; 2024 May; ():. PubMed ID: 38714850
[TBL] [Abstract][Full Text] [Related]
2. TRIM58 Interacts with ZEB1 to Suppress NSCLC Tumor Malignancy by Promoting ZEB1 Protein Degradation via UPP.
Shang R; Chen J; Gao Y; Chen J; Han G
Dis Markers; 2023; 2023():5899662. PubMed ID: 36644609
[TBL] [Abstract][Full Text] [Related]
3. HERC3 promotes YAP/TAZ stability and tumorigenesis independently of its ubiquitin ligase activity.
Yuan B; Liu J; Shi A; Cao J; Yu Y; Zhu Y; Zhang C; Qiu Y; Luo H; Shi J; Cao X; Xu P; Shen L; Liang T; Zhao B; Feng XH
EMBO J; 2023 Feb; 42(4):e111549. PubMed ID: 36598329
[TBL] [Abstract][Full Text] [Related]
4. Predictive and Prognostic Value of TRIM58 Protein Expression in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy.
Zheng YZ; Li JY; Ning LW; Xie N
Breast Cancer (Dove Med Press); 2022; 14():475-487. PubMed ID: 36578908
[TBL] [Abstract][Full Text] [Related]
5. Oviductal Glycoprotein 1 Promotes Hypertension by Inducing Vascular Remodeling Through an Interaction With MYH9.
Bai C; Su M; Zhang Y; Lin Y; Sun Y; Song L; Xiao N; Xu H; Wen H; Zhang M; Ping J; Liu J; Hui R; Li H; Chen J
Circulation; 2022 Nov; 146(18):1367-1382. PubMed ID: 36172862
[TBL] [Abstract][Full Text] [Related]
6. MYH9 is a novel cancer stem cell marker and prognostic indicator in esophageal cancer that promotes oncogenesis through the PI3K/AKT/mTOR axis.
Kai JD; Cheng LH; Li BF; Kang K; Xiong F; Fu JC; Wang S
Cell Biol Int; 2022 Dec; 46(12):2085-2094. PubMed ID: 36030536
[TBL] [Abstract][Full Text] [Related]
7. GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma.
Li Y; Fan Y; Xu J; Huo L; Scott AW; Jin J; Yang B; Shao S; Ma L; Wang Y; Yao X; Pool Pizzi M; Sewastjanow Da Silva M; Zhang G; Zhuo L; Cho EJ; Dalby KN; Shanbhag ND; Wang Z; Li W; Song S; Ajani JA
J Exp Clin Cancer Res; 2022 Aug; 41(1):257. PubMed ID: 35996148
[TBL] [Abstract][Full Text] [Related]
8. TRIM family proteins: roles in proteostasis and neurodegenerative diseases.
Zhu Y; Afolabi LO; Wan X; Shim JS; Chen L
Open Biol; 2022 Aug; 12(8):220098. PubMed ID: 35946309
[TBL] [Abstract][Full Text] [Related]
9. TUBB4A interacts with MYH9 to protect the nucleus during cell migration and promotes prostate cancer via GSK3β/β-catenin signalling.
Gao S; Wang S; Zhao Z; Zhang C; Liu Z; Ye P; Xu Z; Yi B; Jiao K; Naik GA; Wei S; Rais-Bahrami S; Bae S; Yang WH; Sonpavde G; Liu R; Wang L
Nat Commun; 2022 May; 13(1):2792. PubMed ID: 35589707
[TBL] [Abstract][Full Text] [Related]
10. Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures.
Kashyap D; Pal D; Sharma R; Garg VK; Goel N; Koundal D; Zaguia A; Koundal S; Belay A
Biomed Res Int; 2022; 2022():9605439. PubMed ID: 35480139
[TBL] [Abstract][Full Text] [Related]
11. The small molecule chemical compound cinobufotalin attenuates resistance to DDP by inducing ENKUR expression to suppress MYH9-mediated c-Myc deubiquitination in lung adenocarcinoma.
Liu JH; Yang HL; Deng ST; Hu Z; Chen WF; Yan WW; Hou RT; Li YH; Xian RT; Xie YY; Su Y; Wu LY; Xu P; Zhu ZB; Liu X; Deng YL; Wang YB; Liu Z; Fang WY
Acta Pharmacol Sin; 2022 Oct; 43(10):2687-2695. PubMed ID: 35296779
[TBL] [Abstract][Full Text] [Related]
12. GRK3 as a Prognosis Biomarker in Gastric Cancer.
Fang CL; Tian YF; Lin SS; Hung ST; Hseu YC; Chang CC; Chou CL; Chen LC; Wang WC; Lin KY; Sun DP
J Cancer; 2022; 13(4):1299-1306. PubMed ID: 35281865
[No Abstract] [Full Text] [Related]
13. TRIM58 inactivates p53/p21 to promote chemoresistance via ubiquitination of DDX3 in breast cancer.
Wang J; Yang F; Zhuang J; Huo Q; Li J; Xie N
Int J Biochem Cell Biol; 2022 Feb; 143():106140. PubMed ID: 34954155
[TBL] [Abstract][Full Text] [Related]
14. Identification of the molecular function of tripartite motif containing 58 in human lung cancer.
Shi YX
Oncol Lett; 2021 Sep; 22(3):685. PubMed ID: 34434284
[TBL] [Abstract][Full Text] [Related]
15. MYH9-dependent polarization of ATG9B promotes colorectal cancer metastasis by accelerating focal adhesion assembly.
Zhong Y; Long T; Gu CS; Tang JY; Gao LF; Zhu JX; Hu ZY; Wang X; Ma YD; Ding YQ; Li ZG; Wang XY
Cell Death Differ; 2021 Dec; 28(12):3251-3269. PubMed ID: 34131310
[TBL] [Abstract][Full Text] [Related]
16. Cancer Stem Cells: Significance in Origin, Pathogenesis and Treatment of Glioblastoma.
Biserova K; Jakovlevs A; Uljanovs R; Strumfa I
Cells; 2021 Mar; 10(3):. PubMed ID: 33799798
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications.
Zeng X; Liu C; Yao J; Wan H; Wan G; Li Y; Chen N
Pharmacol Res; 2021 Jan; 163():105320. PubMed ID: 33271295
[TBL] [Abstract][Full Text] [Related]
18. Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies.
Walcher L; Kistenmacher AK; Suo H; Kitte R; Dluczek S; Strauß A; Blaudszun AR; Yevsa T; Fricke S; Kossatz-Boehlert U
Front Immunol; 2020; 11():1280. PubMed ID: 32849491
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
